Brief: Ovid Therapeutics Reports Q3 Loss Per Share $0.28
10/11/2021 13:58
Nov 10 (Reuters) - Ovid Therapeutics Inc OVID.O :
* OVID THERAPEUTICS REPORTS THIRD QUARTER 2021 BUSINESS
UPDATE,
CORPORATE HIGHLIGHTS AND FINANCIAL RESULTS
* OVID THERAPEUTICS INC - Q3 LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX50YSvc
Further company coverage: OVID.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors